Vaccine News and Research

Latest Vaccine News and Research

New public resource to help researchers explore data from the NIH human microbiome project

The National Institutes of Health (NIH) has launched the first phase of the Microbiome Cloud Project (MCP), a collaboration with Amazon Web Services that aims to improve access to and analysis of data from the Human Microbiome Project (HMP).

27 Sep 2013

Pittcon to exhibit at BioConference Live’s “Cancer: Research, Discovery and Therapeutics” online-only event

Pittcon is pleased to announce it will be exhibiting at the next BioConference Live virtual event. BioConference Live, the largest producer of online-only conferences focused on life sciences, laboratory animal sciences and clinical diagnostics, has announced the upcoming “Cancer: Research, Discovery and Therapeutics” online-only conference.

26 Sep 2013

New line of –30˚C biomedical freezers launched by Panasonic

Panasonic has launched a brand new line of -30˚C Biomedical freezers that provide cost-efficient and secure sample storage across a wide range of applications. A combination of technological advances in Panasonic’s new -30˚C freezers reduces energy consumption and improves temperature stability, delivering the effective, reliable environmental control needed when storing valuable materials such as vaccines, diagnostic samples, enzymes, culture media and reagents.

From PHC Europe B.V. 26 Sep 2013

Results of NovaRx's Lucanix Phase III trial in non-small cell lung cancer to be presented at ESMO 2013

NovaRx Corporation announced that the detailed results from the randomized Phase III trial of Lucanix (belagenpumatucel-L) post-frontline maintenance therapy in non-small cell lung cancer will be presented at the European Society for Medical Oncology 2013 annual meeting in Amsterdam.

26 Sep 2013

Ten health care innovations could save lives of mothers and children

Ten health care innovations, if brought to scale immediately in low-resource countries, could have the potential to save the lives of some 1.2 million mothers and children in 2015.

26 Sep 2013

MIT engineers develop nanoparticles that deliver cancer vaccines to lungs

Many viruses and bacteria infect humans through mucosal surfaces, such as those in the lungs, gastrointestinal tract and reproductive tract. To help fight these pathogens, scientists are working on vaccines that can establish a front line of defense at mucosal surfaces.

26 Sep 2013

Soligenix awarded $6.4M contract to advance preclinical development of OrbeShield for GI ARS

Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing products to treat inflammatory diseases and biodefense medical countermeasures where there remains an unmet medical need, announced today that it has been awarded a contract valued at up to $6.4 million by the US Department of Health and Human Service's National Institutes of Health (specifically funded by the National Institute of Allergy and Infectious Diseases or NIAID).

25 Sep 2013

Pancreatic Cancer Imaging Agent Earns Mabvax $1.75M SBIR Award

...

24 Sep 2013

JPM, Bill & Melinda Gates Foundation announces capital raise for first-of-its-kind investment product

A new investment fund structured by JPMorgan Chase & Co. (NYSE: JPM) and the Bill & Melinda Gates Foundation will, for the first time, allow individual and institutional investors the opportunity to finance late-stage global health technologies that have the potential to save millions of lives in low-income countries.

24 Sep 2013

Adults across the U.S. rate childhood cancer as top priority for research into improving children's health

Adults across the U.S. rate childhood cancer as their top priority for research into improving children's health, according to a new University of Michigan C.S. Mott Children's Hospital National Poll on Children's Health.

24 Sep 2013

Researchers find reassuring evidence of H1N1 influenza vaccine's safety during pregnancy

Researchers from Boston University's Slone Epidemiology Center and UC San Diego, in collaboration with the American Academy of Allergy Asthma and Immunology, have found 'reassuring' evidence of the H1N1 influenza vaccine's safety during pregnancy.

24 Sep 2013

Survey to measure parental hesitancy linked with childhood immunization status

Scores on a survey to measure parental hesitancy about vaccinating their children were associated with immunization status, according to a study by Douglas J. Opel, M.D., M.P.H., of the University of Washington and Seattle Children's Research Institute, and colleagues.

24 Sep 2013

Researchers find evidence of H1N1 influenza vaccine's safety during pregnancy

Researchers from the University of California, San Diego School of Medicine and Boston University, in collaboration with the American Academy of Allergy Asthma and Immunology (AAAAI), have found evidence of the H1N1 influenza vaccine's safety during pregnancy.

24 Sep 2013

FDA approves STELARA (Ustekinumab) for treatment of active psoriatic arthritis

Janssen Biotech, Inc., announced today that the U.S. Food and Drug Administration (FDA) has approved STELARA® (ustekinumab) alone or in combination with methotrexate for the treatment of adult patients (18 years or older) with active psoriatic arthritis.

23 Sep 2013

Scientists one step closer to developing universal flu vaccine

Scientists have moved closer to developing a universal flu vaccine after using the 2009 pandemic as a natural experiment to study why some people seem to resist severe illness.

23 Sep 2013

Avon Foundation for Women launches competition to bring emerging breast cancer technologies to market

A world-wide competition to bring emerging breast cancer technologies to market is being launched by the Avon Foundation for Women, in partnership with the National Cancer Institute (NCI), part of the NIH, and the Center for Advancing Innovation.

21 Sep 2013

Equatorial Guinea presents design for malaria vaccine trial

Equatorial Guinea's Ministry of Health and Social Security recently presented a design for a malaria vaccine trial as part of the government's efforts to improve the country's public health.

21 Sep 2013

Antibody that binds, neutralizes HIV likely also targets the body's own self proteins

Researchers at The Scripps Research Institute discovered that an antibody that binds and neutralizes HIV likely also targets the body's own "self" proteins. This finding could complicate the development of HIV vaccines designed to elicit this protective antibody, called 4E10, and others like it, as doing so might be dangerous or inefficient.

20 Sep 2013

Viewpoints: Rove warns GOP that defunding could be 'self-defeating;' Jonathan Cohn says latest Obamacare fight reveals Republicans' will to overlook gains from law

Today, independents look more like Republicans than Democrats, especially when it comes to health care. In a new Crossroads GPS health-care policy survey conducted in 10 states likely to have competitive Senate races and in House districts that lean Republican or are swing seats, 60 percent of independents oppose President Obama's Affordable Care Act. If this holds through 2014, then Republicans should receive another big boost in the midterms. There is, however, one issue on which independents disagree with Republicans: using the threat of a government shutdown to defund ObamaCare (Karl Rove, 9/18).

20 Sep 2013

Scientists aim at protecting adults from virulent strain of avian influenza virus

Scientists at the University of Maryland School of Medicine's Center for Vaccine Development are part of nationwide vaccine research aimed at protecting adults from a new and virulent strain of avian (bird) influenza (flu) virus.

20 Sep 2013

Vaccine News and Research

Latest Vaccine News and Research

New public resource to help researchers explore data from the NIH human microbiome project

Pittcon to exhibit at BioConference Live’s “Cancer: Research, Discovery and Therapeutics” online-only event

New line of –30˚C biomedical freezers launched by Panasonic

Results of NovaRx's Lucanix Phase III trial in non-small cell lung cancer to be presented at ESMO 2013

Ten health care innovations could save lives of mothers and children

MIT engineers develop nanoparticles that deliver cancer vaccines to lungs

Soligenix awarded $6.4M contract to advance preclinical development of OrbeShield for GI ARS

Pancreatic Cancer Imaging Agent Earns Mabvax $1.75M SBIR Award

JPM, Bill & Melinda Gates Foundation announces capital raise for first-of-its-kind investment product

Adults across the U.S. rate childhood cancer as top priority for research into improving children's health

Researchers find reassuring evidence of H1N1 influenza vaccine's safety during pregnancy

Survey to measure parental hesitancy linked with childhood immunization status

Researchers find evidence of H1N1 influenza vaccine's safety during pregnancy

FDA approves STELARA (Ustekinumab) for treatment of active psoriatic arthritis

Scientists one step closer to developing universal flu vaccine

Avon Foundation for Women launches competition to bring emerging breast cancer technologies to market

Equatorial Guinea presents design for malaria vaccine trial

Antibody that binds, neutralizes HIV likely also targets the body's own self proteins

Viewpoints: Rove warns GOP that defunding could be 'self-defeating;' Jonathan Cohn says latest Obamacare fight reveals Republicans' will to overlook gains from law

Scientists aim at protecting adults from virulent strain of avian influenza virus

Industry Focus eBook - Infectious Diseases (2nd Edition) eBook

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Vaccine News and Research

Latest Vaccine News and Research

Industry Focus eBook - Infectious Diseases (2nd Edition) eBook

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Newsletters you may be interested in